Renin-angiotensin system mediated mechanisms: cardioreparation and cardioprotection.
Brilla
C G
CG
Klinikum der Philipps Universität, Zentrum f. Innere Medizin/Kardiologie, Marburg, Germany. brilla@t-online.de
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005355:Fibrosis; D006333:Heart Failure / Q000150:complications* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D017379:Hypertrophy, Left Ventricular / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D017706:Lisinopril / Q000627:therapeutic use; D008297:Male; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D011918:Rats, Inbred SHR; D012084:Renin-Angiotensin System / Q000187:drug effects*; D020257:Ventricular Remodeling / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D006852:Hydrochlorothiazide; D017706:Lisinopril